Arbe Given 180 Days to Restore $1 Minimum Bid Price After Nasdaq Notice
Arbe's ordinary shares closed below the $1 minimum bid price for 30 consecutive business days, triggering a Nasdaq listing deficiency notice on April 13, 2026. Nasdaq has granted a 180-calendar-day compliance period until October 12, 2026, with a potential additional 180 days if Arbe meets other listing standards.
1. Nasdaq Notification and Deficiency Details
On April 13, 2026, the company received a notification from Nasdaq’s Listing Qualifications Department stating that its ordinary shares had traded below the required $1 minimum bid price for the previous 30 consecutive business days. The notice does not affect current trading, and the shares will remain listed under the same trading symbol.
2. Compliance Timeline and Cure Options
Nasdaq has provided a 180-calendar-day period, expiring on October 12, 2026, for Arbe to regain compliance with the minimum bid price rule. If the company meets all other initial listing standards for The Nasdaq Capital Market except the bid-price requirement, it may seek an additional 180-day extension by delivering written notice and, if necessary, executing a reverse stock split.
3. Potential Consequences and Company Response
If Arbe fails to cure the deficiency or is deemed ineligible for the extension, Nasdaq will issue a delisting notice and initiate removal procedures. The company is actively evaluating strategic options to restore compliance but has indicated there is no guarantee of success within the prescribed timelines.